Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2002
Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative Group
G Bonadonna, M Zambetti, C Bumma, et al.
Tumori
|
August 31, 1994
Dose intensification of chemotherapy in advanced breast cancer: a feasibility phase II study
P Pedrazzoli, C Zamagni, A Martoni, et al.
Journal of Chemotherapy (Florence, Italy)
|
June 12, 2003
Randomized, controlled, multicenter phase III trial of standard-dose fluorouracil-epirubicin-cyclophosphamide (FEC), compared with time-intensive FEC (FEC-G) and mitoxantrone-methotrexate-mitomycin C (MMM-G) in metastatic breast carcinoma
A M Capotorto, L Pavesi, P Pedrazzoli, et al.
American Journal of Clinical Oncology
|
January 22, 2002
Prospective phase II study of single-agent gemcitabine in untreated elderly patients with stage IIIB/IV non-small-cell lung cancer
A Martoni, F Di Fabio, M Guaraldi, et al.
Tumori
|
July 1, 1996
A new regimen of cisplatin, epirubicin and methotrexate (PEM-3) as primary chemotherapy for locally advanced bladder cancer
N Cacciari, A Martoni, A P Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer
S Cresta, G Grasselli, M Mansutti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours
J-L Pico, G Rosti, A Kramar, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 9, 2008
The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: outcome study in clinical practice
G Lelli, S Cataldo, I Carandina, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 30, 1998
Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer
A Martoni, M Guaraldi, E Piana, et al.
Neuro-Oncology Practice
|
June 3, 2015
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?
Alba A Brandes, Enrico Franceschi, Mario Ermani, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2002
Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative Group
G Bonadonna, M Zambetti, C Bumma, et al.
Tumori
|
August 31, 1994
Dose intensification of chemotherapy in advanced breast cancer: a feasibility phase II study
P Pedrazzoli, C Zamagni, A Martoni, et al.
Journal of Chemotherapy (Florence, Italy)
|
June 12, 2003
Randomized, controlled, multicenter phase III trial of standard-dose fluorouracil-epirubicin-cyclophosphamide (FEC), compared with time-intensive FEC (FEC-G) and mitoxantrone-methotrexate-mitomycin C (MMM-G) in metastatic breast carcinoma
A M Capotorto, L Pavesi, P Pedrazzoli, et al.
American Journal of Clinical Oncology
|
January 22, 2002
Prospective phase II study of single-agent gemcitabine in untreated elderly patients with stage IIIB/IV non-small-cell lung cancer
A Martoni, F Di Fabio, M Guaraldi, et al.
Tumori
|
July 1, 1996
A new regimen of cisplatin, epirubicin and methotrexate (PEM-3) as primary chemotherapy for locally advanced bladder cancer
N Cacciari, A Martoni, A P Rossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer
S Cresta, G Grasselli, M Mansutti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours
J-L Pico, G Rosti, A Kramar, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 9, 2008
The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: outcome study in clinical practice
G Lelli, S Cataldo, I Carandina, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 30, 1998
Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer
A Martoni, M Guaraldi, E Piana, et al.
Neuro-Oncology Practice
|
June 3, 2015
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?
Alba A Brandes, Enrico Franceschi, Mario Ermani, et al.
Page
of 4